Susquehanna International Group, LLP Clovis Oncology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $88,620 - $240,540	-84,400 Reduced 14.84%	484,400 $576,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $67,725 - $318,200	107,500 Added 23.3%	568,800 $1.02 Million
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $12,012 - $26,376	-8,400 Reduced 1.79%	461,300 $932,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $856,710 - $1.51 Million	-317,300 Reduced 40.32%	469,700 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $192,037 - $274,340	-47,300 Reduced 5.67%	787,000 $3.51 Million
Q2 2021 Aug 11, 2021	SELL	$5.02 - $7.05 $171,182 - $240,405	-34,100 Reduced 3.93%	834,300 $4.84 Million
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $767,194 - $1.65 Million	159,500 Added 22.5%	868,400 $6.1 Million
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $984,179 - $1.53 Million	238,300 Added 50.64%	708,900 $3.4 Million
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $115,198 - $184,508	-23,900 Reduced 4.83%	470,600 $2.74 Million
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $3.75 Million - $6.39 Million	-659,600 Reduced 57.15%	494,500 $3.34 Million
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $3.42 Million - $9.97 Million	-906,700 Reduced 44.0%	1,154,100 $7.34 Million
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $4.84 Million - $26.5 Million	1,614,400 Added 361.65%	2,060,800 $21.5 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $736,089 - $2.88 Million	187,300 Added 72.29%	446,400 $1.75 Million
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $426,573 - $854,811	-33,300 Reduced 11.39%	259,100 $3.85 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $9.49 Million - $16.3 Million	-537,300 Reduced 64.76%	292,400 $7.26 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $6.24 Million - $17.5 Million	536,400 Added 182.88%	829,700 $14.9 Million
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $26.9 Million - $45.3 Million	-915,900 Reduced 75.74%	293,300 $8.61 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $38.3 Million - $56.9 Million	911,700 Added 306.45%	1,209,200 $55 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $27.5 Million - $37.1 Million	-548,100 Reduced 64.82%	297,500 $15.7 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $24.3 Million - $35.6 Million	420,500 Added 98.92%	845,600 $57.5 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $28.6 Million - $36.1 Million	425,100	425,100 $35 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account